AIMED BIO INC. – Trademark Portfolio

Entity Type: 03

AIMED BIO INC. has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include AVATASCAN. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 10 (Medical Apparatus). This trademark owner is based in SEOUL.

11TH FL. MK BLD, 67, JEONGUI-RO,

SONGPA-GU

SEOUL 05835 , KR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AIMED BIO INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does AIMED BIO INC. have?

AIMED BIO INC. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does AIMED BIO INC. file in?

AIMED BIO INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are AIMED BIO INC.'s most well-known trademarks?

AIMED BIO INC.'s registered trademark portfolio includes well-known marks such as AVATASCAN. These are among 1 currently registered trademark in the portfolio.

What is AIMED BIO INC.'s trademark registration success rate?

AIMED BIO INC. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.